Sudarshan Pharma CS and Compliance Officer Nirav Shah Resigns
Sudarshan Pharma Industries Ltd 路 Change in Management 路 09 Nov 2026, 11:16 pm
Sudarshan Pharma CS and Compliance Officer Nirav Shah Resigns Sudarshan Pharma Industries announced the resignation of Nirav Shah from the position of Company Secretary and Compliance Officer, effective 9th Nov'26. According to the regulatory disclosure under SEBI LODR Regulation 30, the resignation is attributed to pursuing better professional prospects, with no other material reasons reported. The company confirmed that Shah holds no familial relationships with any of its directors.
Original exchange filing (PDF)
More announcements from Sudarshan Pharma Industries Ltd
- In terms of Regulation 30 read with Para A of Part A of Schedule III to the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, we hereby submit the updated Investor .... 路 07 Nov 2026
- In continuation of the Company''s letter dated 30/Oct/2026 (ref. no. SPIL/CS/2026-2027/72), the Board of Directors at its Meeting held on 29/Oct/2026 have approved the proposal to raising .... 路 31 Oct 2026
- This is to inform you that the Board of Directors of the Company at its Board Meeting held on 29/Oct/2026 has approved the proposal to raising funds through issue and allotment of up to .... 路 30 Oct 2026
- We are submitting herewith the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30/Sep/2026 路 30 Oct 2026
- We are submitting the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30/Sep/2026 路 30 Oct 2026
- Sudarshan Pharma Industries Limited has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Fund raising. 路 29 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 and Fund Raising 路 29 Oct 2026
- Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve i) Unaudited Standalone .... 路 29 Oct 2026
